You can buy Orlistat (Xenical/Alli) as an over-the-counter alternative to Wegovy in the UK.
However, Orlistat is a very different type of weight-loss medication, and research suggests it’s not as effective as Wegovy in supporting weight loss.
Wegovy and Orlistat are weight-loss medications approved for use in the UK. However, they are different medications with distinct dosing schedules, costs, and mechanisms of action on the body.
Orlistat is a lipase inhibitor. Lipases are gut enzymes that break down fat from food, enabling the gut to transport fat into the body to be burnt for energy or stored in our fat cells for later use.
Orlistat blocks lipases, preventing some of the dietary fat from our meals from being digested. This leads to fewer calories being absorbed, which can support weight loss.
Orlistat is a prescription medication produced by two pharmaceutical companies in the UK:
Wegovy is a weight-loss jab manufactured by Novo Nordisk. It’s a weekly weight-loss injection with semaglutide as the active ingredient.
Semaglutide is a that helps reduce hunger and appetite, allowing you to eat fewer calories, lose weight, and manage your blood sugar levels.
Wegovy is approved in the UK for individuals living with obesity to help them eat fewer calories and lose weight.
The over-the-counter version of Orlistat will cost around £18 a month, so it’s a very affordable medication.
In comparison, buying Wegovy and the injectable pens required for four weeks from Second Nature will cost £229 a month, rising to £299.
Orlistat is an affordable medication that is generally well-tolerated. However, it’s less effective than Wegovy. Wegovy is twice as effective as Orlistat for weight loss after one year.
So, if you’re looking for the most affordable weight-loss pill you can purchase over the counter, then Orlistat could be an option.
However, if you have a higher budget and are looking for the most effective weight-loss injection in the UK, semaglutide is a better choice.
Semaglutide is designed as an additional tool for weight management and, in most cases, shouldn’t be considered a lifelong medication.
Instead, it should be used to help you kickstart your weight loss and healthy journey while you commit to living a healthier lifestyle.
Ideally, we’d be able to lose weight without medication and lifestyle changes would be enough to support weight loss in the long term.
We’d generally recommend trying Second Nature’s before considering a weight-loss jab.
Changing your habits is the most sustainable way to achieve long-term weight loss, and it’s also less expensive.
At Second Nature, we’ve been trusted by the NHS since 2017 to support people with type 2 diabetes and obesity to lose weight, manage their blood sugar levels, and lead healthier lifestyles for the long term.
In 2022, the NHS in the BMJ that compared the weight loss outcomes of five providers in the National Diabetes Prevention Programme.
Second Nature was more than twice as effective at supporting weight loss than the other four providers.
However, if you’ve decided to try semaglutide (when it’s available) but need support in making positive changes to your lifestyle, Second Nature could be an option for you. But it’s worth noting that we have strict eligibility criteria.
Second Nature has a team-based pricing program and our top-notch research and use members’ experience and knowledge.Ourethylenediamine research team has played a significant role in supporting our work and leading our participants into weight loss treatment.
Xenical (orlistat) is an innovative weight loss medication that aids individuals in managing obesity by inhibiting the absorption of dietary fats in the intestine. Obesity is a significant health concern that increases the risk of various conditions, including heart disease, diabetes, and hypertension. Xenical offers a unique approach to weight management by preventing the breakdown and absorption of about 30% of the fat consumed in a meal, which is then excreted from the body. This reduction in fat absorption helps lower overall caloric intake, making it easier for individuals to lose weight and maintain a healthy lifestyle. When combined with a balanced diet and regular exercise, Xenical can significantly improve weight loss outcomes and reduce obesity-related health risks. It is a valuable tool for those struggling with weight management, providing support and efficacy in achieving long-term weight loss goals.
Benefits of Xenical:
Dosage:
Warnings and Precautions:
Usage Instructions:
Storage Information:
Common Side Effects:
Xenical 120mg Capsules,when used in conjunction with a reduced-calorie diet, can be used for obesity management, including weight loss and weight maintenance.Xenicalworks in your digestive system to block one-third of the fat in the food you eat from being digestedThe daily intake of fat, carbohydrate and protein should be distributed over three main meals.pills can also block the absorption of some vitamins. You may wish to take a multivitamin supplement along with making sure to keep a well-balanced diet, rich in fruit and vegetables.
The active substance isOrlistat. Each capsule contains120 mg of Orlistat
The other ingredients are microcrystalline cellulose (E460), sodium starch glycolate (type A), povidone (E1201), sodium laurilsulfate and talc. The capsule shell consists of gelatine, indigo carmine (E132), titanium dioxide (E171) and edible printing ink.
84 Capsules
We’re on the shortlist of three items forrative index increase.The most common side effects are:
For the full list of side effects, please refer to the customer service’s supplied with you can monitor any side effect you experience with this drug.
If you are allergic to Orlistat or any of the other ingredients of this product, you should not take Xenical 120mg Capsules:
If you are pregnant or breast-feeding, you should consult a healthcare professional before taking this product.
The most common side effects are constipation, dizziness, and fatigue. You should contact your doctor if you experience these side effects while taking this medicine. You should contact taking Orlistat 120mg Capsules:
If any of these side effects persist or become problematic, call your healthcare professional immediately.
Boots, the world’s largest prescription drugmaker, is launching a new weight-loss pill for women.
Eli Lilly and Company (Lilly), based in Indianapolis, is launching a new, new weight-loss pill for women.
The first pill is called Xenical, which contains the active ingredient orlistat, as the brand is called in the United States.
The new pill, which is made by AstraZeneca, will be available in a range of strengths, including 120 mg and 120 mg capsules, each containing 60 mg of orlistat.
AstraZeneca is also selling the drug.
Lilly has a market share of about 30 percent, compared with about 20 percent in the US.
Lilly is the world’s biggest pharmaceutical company by revenue, with a market capitalization of around $2.3 billion, according to IMS Health, a health information company that tracks pharmaceutical companies.
The company is in the process of launching a joint venture with Merck & Co. to provide a combined revenue of about $30.8 billion, including $8.6 billion in sales in the US.
The company also will focus on consumer healthcare and the consumer health business.
Lilly’s revenue is expected to be around $3.2 billion by 2024, and about $4.1 billion by 2031.
Lilly is the world’s largest pharmaceutical company by market capitalization. Its market capitalization is about $14.4 billion, according to IMS Health.
The US has the largest revenue share of the major pharmaceutical companies in the world, accounting for a third of its total revenue in 2024, according to IMS Health.
Lilly has an annual revenue growth rate of 8.5 percent and a sales growth rate of about 2.2 percent.
Lilly also has a sales force of more than 3,000 people, according to IMS Health.
Lilly has a combined annual sales of about $11.2 billion, including about $7.1 billion in sales in the US.
Lilly is also the world’s largest generic drugmaker, based in London.
Lilly is one of the largest drug makers in the world, with a combined annual revenue of about $20.2 billion.
Lilly has about 5.1 percent of the global pharmaceutical market, according to IMS Health, while the drugmaker has a market share of about 4 percent.
Lilly is also the world’s largest drugmaker, with a market share of about 6 percent.
Lilly’s sales of more than $6 billion are projected to grow by around 20 percent.
Lilly (NYSE: LLY), based in Cambridge, Mass. and AstraZeneca (LSE: ZEN), in collaboration with AstraZeneca, in collaboration with Bristol-Myers Squibb, in collaboration with Merck & Co., in collaboration with Eli Lilly and Company, in collaboration with GlaxoSmithKline, in collaboration with Bayer and Novartis, in collaboration with Pfizer.Lilly (NYSE: LLL), based in Cambridge, Mass.
Stade de France Pharmacy